ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,580Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 198

$805K Total Retail Price of All Prescriptions

Rank: 21 out of 198

871 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 871 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 871 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 12,289 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 600 558 1 1
SIMVASTATIN 527 485 2 2
AMLODIPINE BESYLATE 440 418 3 4
OMEPRAZOLE 422 351 4 3
METOPROLOL SUCCINATE 366 359 5 11
MELOXICAM 331 310 6 30
HYDROCODONE-ACETAMINOPHEN 324 255 S3 7 8
FUROSEMIDE 323 299 8 5
LISINOPRIL 299 275 9 6
WARFARIN SODIUM 285 276 10 7
PRAVASTATIN SODIUM 275 251 11 19
ATORVASTATIN CALCIUM 266 261 12 12
METOPROLOL TARTRATE 241 229 13 10
POTASSIUM CHLORIDE 238 238 14 9
METFORMIN HCL 199 192 15 13
ZOLPIDEM TARTRATE 198 168 16 22
TAMSULOSIN HCL 191 188 17 27
SERTRALINE HCL 186 153 18 25
TRAZODONE HCL 165 137 19 50
HYDROCHLOROTHIAZIDE 149 136 20 16
PANTOPRAZOLE SODIUM 147 118 21 31
ZETIA 136 136 22 68
CRESTOR 133 127 23 26
LOSARTAN POTASSIUM 129 110 24 18
TRIAMTERENE-HCTZ 127 113 25 32
FLUTICASONE PROPIONATE 123 110 26 39
GABAPENTIN 118 102 27 14
DONEPEZIL HCL 110 110 28 28
DIOVAN 108 95 29 34
ALLOPURINOL 107 94 30 23
TRAMADOL HCL 106 100 31 15
NAMENDA 105 105 32 33
ATENOLOL 98 94 33 17
BENAZEPRIL HCL 95 83 34 45
ALENDRONATE SODIUM 91 87 35 21
MIRTAZAPINE 86 86 36 44
CITALOPRAM HBR 82 71 37 20
SYNTHROID 79 67 38 36
KLOR-CON M20 78 64 39 137
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 72 40 38
CIPROFLOXACIN HCL 74 72 41 55
AZITHROMYCIN 73 64 42 56
CYMBALTA 72 67 43 48
PROPRANOLOL HCL 72 59 43 92
CARVEDILOL 71 71 45 24
DIOVAN HCT 70 70 46 88
CLONIDINE HCL 69 50 47 52
GLIPIZIDE 68 66 48 62
LEVOFLOXACIN 68 63 48 81
PREMARIN 67 63 R 50 101
LOSARTAN-HYDROCHLOROTHIAZIDE 67 66 50 49
OXYCONTIN 67 18 S2 50 151
PREDNISONE 67 57 50 29
FLUOXETINE HCL 66 47 54 78
NEXIUM 64 64 55 40
DIGOXIN 62 58 56 43
ADVAIR DISKUS 61 56 57 47
TRICOR 57 42 58 93
ISOSORBIDE MONONITRATE ER 57 57 58 60
LANTUS SOLOSTAR 57 45 58 85
LANSOPRAZOLE 55 41 61 166
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 52 62 90
LOVASTATIN 51 38 63 70
BUTALB-CAFF-ACETAMINOPH-CODEIN 51 49 S3 R 63 286
CLOPIDOGREL 50 50 65 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.